Accredited Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,845
| Closed | -$66.7K | – | 247 |
|
|
2024
Q3 | $66.7K | Buy |
+12,845
| New | +$66.7K | ﹤0.01% | 232 |
|
|
2024
Q2 | – | Sell |
-12,845
| Closed | -$63.2K | – | 233 |
|
|
2024
Q1 | $63.2K | Hold |
12,845
| – | – | ﹤0.01% | 209 |
|
|
2023
Q4 | $113K | Hold |
12,845
| – | – | 0.01% | 192 |
|
|
2023
Q3 | $147K | Hold |
12,845
| – | – | 0.01% | 188 |
|
|
2023
Q2 | $325K | Sell |
12,845
-7,646
| -37% | -$194K | 0.02% | 139 |
|
|
2023
Q1 | $660K | Hold |
20,491
| – | – | 0.05% | 93 |
|
|
2022
Q4 | $378K | Hold |
20,491
| – | – | 0.03% | 122 |
|
|
2022
Q3 | $553K | Hold |
20,491
| – | – | 0.06% | 93 |
|
|
2022
Q2 | $283K | Hold |
20,491
| – | – | 0.03% | 142 |
|
|
2022
Q1 | $400K | Hold |
20,491
| – | – | 0.04% | 129 |
|
|
2021
Q4 | $334K | Hold |
20,491
| – | – | 0.03% | 138 |
|
|
2021
Q3 | $571K | Hold |
20,491
| – | – | 0.06% | 95 |
|
|
2021
Q2 | $607K | Hold |
20,491
| – | – | 0.06% | 95 |
|
|
2021
Q1 | $573K | Hold |
20,491
| – | – | 0.08% | 90 |
|
|
2020
Q4 | $581K | Buy |
+20,491
| New | +$581K | 0.1% | 87 |
|